NRX Pharmaceuticals Inc (NRXP)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
129,671,000
EV to revenue ratio (TTM)
32.82
EV to ebitda
-0.151
Financial Performance
Revenue (TTM)
3,394,000
Gross profit (TTM)
1,583,000
EBITDA
-19,762,000
Profitability
Operating margin (TTM)
-590.00%
Profit margin
0.00%
Return on assets (TTM)
-64.00%
Return on equity (TTM)
-683.00%
Per Share Metrics
Revenue per share (TTM)
0.11
EPS
-0.51
Diluted EPS (TTM)
-0.51
Book value
0
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
34.25
PEG ratio
Price to sales ratio (TTM)
38.21
Price to book ratio (TTM)
2.904
Growth
Quarterly earnings growth (YoY)
0.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
0
Buy
4
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
2.188